Susquehanna International Group (Ireland)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
HA
CII
Susquehanna International Group (Ireland)'s ONC Position: Q1 2023 in Review
Susquehanna International Group (Ireland) sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 2,500 shares — an estimated $550K sold.
Susquehanna International Group (Ireland) first reported a position in ONC in Q2 2022 and held it in 2 quarters. The position peaked at $647K in Q2 2022. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.
- Susquehanna International Group (Ireland) reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group (Ireland) sold 2,500 BeOne Medicines Ltd shares in Q1 2023, an estimated $550K.
- Susquehanna International Group (Ireland) first reported a position in BeOne Medicines Ltd in Q2 2022 and held it in 2 quarters.
- Susquehanna International Group (Ireland)'s BeOne Medicines Ltd position peaked at $647K in Q2 2022.
- 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.
Based on Susquehanna International Group (Ireland)'s 13F filing for Q1 2023, filed 16 May 2023.